文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

钾通道:肿瘤诊断与化疗耐药性的新靶点。

Potassium channels: Novel targets for tumor diagnosis and chemoresistance.

作者信息

Li Meizeng, Tian Peijie, Zhao Qing, Ma Xialin, Zhang Yunxiang

机构信息

School of Basic Medical Science, Weifang Medical University, Weifang, China.

Department of Pathology, Weifang People' s Hospital, Weifang, China.

出版信息

Front Oncol. 2023 Jan 10;12:1074469. doi: 10.3389/fonc.2022.1074469. eCollection 2022.


DOI:10.3389/fonc.2022.1074469
PMID:36703789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9872028/
Abstract

In recent years, the role of potassium channels in tumors has been intensively studied. Potassium channel proteins are widely involved in various physiological and pathological processes of cells. The expression and dysfunction of potassium channels are closely related to tumor progression. Potassium channel blockers or activators present antitumor effects by directly inhibiting tumor growth or enhancing the potency of classical antitumor agents in combination therapy. This article reviews the mechanisms by which potassium channels contribute to tumor development in various tumors in recent years, introduces the potential of potassium channels as diagnostic targets and therapeutic means for tumors, and provides further ideas for the proper individualized treatment of tumors.

摘要

近年来,钾通道在肿瘤中的作用受到了深入研究。钾通道蛋白广泛参与细胞的各种生理和病理过程。钾通道的表达及功能障碍与肿瘤进展密切相关。钾通道阻滞剂或激活剂通过直接抑制肿瘤生长或在联合治疗中增强经典抗肿瘤药物的效力而呈现出抗肿瘤作用。本文综述了近年来钾通道在各类肿瘤中促进肿瘤发展的机制,介绍了钾通道作为肿瘤诊断靶点和治疗手段的潜力,并为肿瘤的合理个体化治疗提供进一步思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba3/9872028/fb7d23ecd89e/fonc-12-1074469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba3/9872028/3bf0cf9b6b27/fonc-12-1074469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba3/9872028/fb7d23ecd89e/fonc-12-1074469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba3/9872028/3bf0cf9b6b27/fonc-12-1074469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba3/9872028/fb7d23ecd89e/fonc-12-1074469-g002.jpg

相似文献

[1]
Potassium channels: Novel targets for tumor diagnosis and chemoresistance.

Front Oncol. 2023-1-10

[2]
Potassium channel blockers and openers as CNS neurologic therapeutic agents.

Recent Pat CNS Drug Discov. 2007-11

[3]
Medicinal Chemistry of Potassium Channel Modulators: An Update of Recent Progress (2011-2017).

Curr Med Chem. 2019

[4]
K(+) channels as therapeutic targets in oncology.

Future Med Chem. 2010-5

[5]
Molecular Pharmacology of K Potassium Channels.

Cell Physiol Biochem. 2021-3-6

[6]
Potassium channels and epilepsy.

Acta Neurol Scand. 2022-12

[7]
A "Target Class" Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels.

SLAS Discov. 2021-3

[8]
Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.

J Dent Res. 2005-6

[9]
Chloride channels in cancer: Focus on chloride intracellular channel 1 and 4 (CLIC1 AND CLIC4) proteins in tumor development and as novel therapeutic targets.

Biochim Biophys Acta. 2015-10

[10]
K(+) channels as therapeutic drug targets.

Pharmacol Ther. 2002

引用本文的文献

[1]
Cell Settling, Migration, and Stochastic Cancer Gene Expression Suggest Potassium Membrane Flux May Initiate pH Reversal.

Biomolecules. 2025-8-16

[2]
BK channel as a novel regulator of cellular DNA damage response in human bronchial epithelial cells in the presence of particulate matter.

Sci Rep. 2025-7-2

[3]
Decoding Potassium Homeostasis in Cancer Metastasis and Drug Resistance: Insights from a Highly Selective DNAzyme-Based Intracellular K Sensor.

J Am Chem Soc. 2025-5-28

[4]
The physiological characteristics of inward rectifying potassium channel Kir4.2 and its research progress in human diseases.

Front Cell Dev Biol. 2025-4-24

[5]
Combining Sulfonylureas with Anticancer Drugs: Evidence of Synergistic Efficacy with Doxorubicin In Vitro and In Vivo.

Int J Mol Sci. 2025-2-8

[6]
Potassium KCa3.1 channel overexpression deteriorates functionality and availability of channels at the outer cellular membrane.

Sci Rep. 2025-2-10

[7]
Targeting ion channels: innovative approaches to combat cancer drug resistance.

Theranostics. 2025-1-1

[8]
Drug Repurposing for Cancer Treatment: A Comprehensive Review.

Int J Mol Sci. 2024-11-19

[9]
Anti-CLL1 liposome loaded with miR-497-5p and venetoclax as a novel therapeutic strategy in acute myeloid leukemia.

Mol Ther. 2024-11-6

[10]
ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway.

J Nanobiotechnology. 2024-9-12

本文引用的文献

[1]
KCNK3 inhibits proliferation and glucose metabolism of lung adenocarcinoma via activation of AMPK-TXNIP pathway.

Cell Death Discov. 2022-8-13

[2]
Downregulation of IL-8 and IL-10 by the Activation of Ca-Activated K Channel K3.1 in THP-1-Derived M Macrophages.

Int J Mol Sci. 2022-8-3

[3]
Pharmacological Activation of Potassium Channel Kv11.1 with NS1643 Attenuates Triple Negative Breast Cancer Cell Migration by Promoting the Dephosphorylation of Caveolin-1.

Cells. 2022-8-8

[4]
hERG1 Potassium Channel Expression in Colorectal Adenomas: Comparison with Other Preneoplastic Lesions of the Gastrointestinal Tract.

Curr Issues Mol Biol. 2022-3-17

[5]
KCNN4 is a Potential Biomarker for Predicting Cancer Prognosis and an Essential Molecule that Remodels Various Components in the Tumor Microenvironment: A Pan-Cancer Study.

Front Mol Biosci. 2022-6-3

[6]
The Repression of Matrix Metalloproteinases and Cytokine Secretion in Glioblastoma by Targeting K+ Channel.

Basic Clin Neurosci. 2021

[7]
Design of New Potent and Selective Thiophene-Based K1.3 Inhibitors and Their Potential for Anticancer Activity.

Cancers (Basel). 2022-5-24

[8]
Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer.

Front Cell Dev Biol. 2022-5-17

[9]
Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine.

Clin Exp Metastasis. 2022-8

[10]
The role of potassium channels in the proliferation and migration of endometrial adenocarcinoma HEC1-A cells.

Mol Biol Rep. 2022-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索